DE3629052C2 - Antitumor-Antibiotika - Google Patents

Antitumor-Antibiotika

Info

Publication number
DE3629052C2
DE3629052C2 DE3629052A DE3629052A DE3629052C2 DE 3629052 C2 DE3629052 C2 DE 3629052C2 DE 3629052 A DE3629052 A DE 3629052A DE 3629052 A DE3629052 A DE 3629052A DE 3629052 C2 DE3629052 C2 DE 3629052C2
Authority
DE
Germany
Prior art keywords
bbm
vol
shows
methanol
spectrum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3629052A
Other languages
German (de)
English (en)
Other versions
DE3629052A1 (de
Inventor
Jerzey Golik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DE3629052A1 publication Critical patent/DE3629052A1/de
Application granted granted Critical
Publication of DE3629052C2 publication Critical patent/DE3629052C2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03—Actinomadura

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE3629052A 1985-08-27 1986-08-27 Antitumor-Antibiotika Expired - Fee Related DE3629052C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77033585A 1985-08-27 1985-08-27

Publications (2)

Publication Number Publication Date
DE3629052A1 DE3629052A1 (de) 1987-05-07
DE3629052C2 true DE3629052C2 (de) 1995-09-28

Family

ID=25088206

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3629052A Expired - Fee Related DE3629052C2 (de) 1985-08-27 1986-08-27 Antitumor-Antibiotika

Country Status (26)

Country Link
JP (2) JPH0733393B2 (fr)
KR (1) KR920010226B1 (fr)
AT (1) AT392971B (fr)
AU (1) AU604464B2 (fr)
BE (1) BE905332A (fr)
CA (1) CA1307256C (fr)
CH (1) CH668598A5 (fr)
CY (1) CY1676A (fr)
DE (1) DE3629052C2 (fr)
DK (1) DK170671B1 (fr)
ES (1) ES2002728A6 (fr)
FI (1) FI83422C (fr)
FR (1) FR2586686B1 (fr)
GB (1) GB2179649A (fr)
GR (1) GR862160B (fr)
HK (1) HK793A (fr)
HU (1) HU197915B (fr)
IE (1) IE59204B1 (fr)
IL (1) IL79519A0 (fr)
IT (1) IT1229176B (fr)
LU (1) LU86562A1 (fr)
NL (1) NL8602165A (fr)
PT (1) PT83261B (fr)
SE (2) SE469632B (fr)
SG (1) SG109692G (fr)
ZA (1) ZA865796B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE219096T1 (de) * 1987-01-30 2002-06-15 American Cyanamid Co Dihydroderivate der antibiotika vom typ ll-e33288
US4916065A (en) * 1988-06-10 1990-04-10 Bristol-Myers Company BU-3420T Antitumor antibiotic
US5028536A (en) * 1989-03-15 1991-07-02 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41339
US5086045A (en) * 1989-03-15 1992-02-04 Bristol-Myers Squibb Company Antitumor antibiotic
CA2027601A1 (fr) * 1989-11-06 1991-05-07 Koko Sugawara Antibiotique antitumeur bu-3983t
CA2039789A1 (fr) * 1990-04-27 1991-10-28 Samuel J. Danishefsky Calicheamicinone, derives et analogues, et methodes de fabrication
US5116845A (en) * 1990-05-04 1992-05-26 Bristol-Myers Company BU-3420T antitumor antibiotic
US5264586A (en) * 1991-07-17 1993-11-23 The Scripps Research Institute Analogs of calicheamicin gamma1I, method of making and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3148023A1 (de) * 1981-12-04 1983-06-09 Rudolf Dipl.-Ing. 8901 Oberottmarshausen Fischer Heizungskessel fuer heisse rauchgase
US4578271A (en) * 1982-05-24 1986-03-25 Fujisawa Pharmaceutical Co., Ltd. Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions
NZ208013A (en) * 1983-05-16 1987-07-31 Bristol Myers Co Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora
JPS606194A (ja) * 1983-06-23 1985-01-12 Meiji Seika Kaisha Ltd 新規抗生物質ｓｆ−２２８８及びその製造法
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production

Also Published As

Publication number Publication date
SG109692G (en) 1992-12-24
IL79519A0 (en) 1986-10-31
FI863405A0 (fi) 1986-08-22
IT1229176B (it) 1991-07-23
IE862280L (en) 1987-02-27
PT83261A (en) 1986-09-01
ZA865796B (en) 1987-04-29
ES2002728A6 (es) 1988-10-01
FR2586686A1 (fr) 1987-03-06
IE59204B1 (en) 1994-01-26
DK170671B1 (da) 1995-11-27
IT8621527A0 (it) 1986-08-26
AU6175186A (en) 1987-03-05
CA1307256C (fr) 1992-09-08
HK793A (en) 1993-01-15
GB8620118D0 (en) 1986-10-01
SE8603597D0 (sv) 1986-08-26
JPH07233186A (ja) 1995-09-05
GR862160B (en) 1986-12-31
SE469632B (sv) 1993-08-09
AT392971B (de) 1991-07-25
FI83422C (fi) 1991-07-10
SE9200428L (sv) 1993-08-14
PT83261B (pt) 1989-05-12
JPS62116589A (ja) 1987-05-28
JPH0733393B2 (ja) 1995-04-12
FI863405L (fi) 1987-02-28
NL8602165A (nl) 1987-03-16
DE3629052A1 (de) 1987-05-07
CY1676A (en) 1993-10-10
GB2179649A (en) 1987-03-11
HU197915B (en) 1989-06-28
KR920010226B1 (ko) 1992-11-21
SE9200428D0 (sv) 1992-02-13
BE905332A (fr) 1987-02-26
SE8603597L (sv) 1987-02-28
CH668598A5 (de) 1989-01-13
LU86562A1 (fr) 1987-03-06
FI83422B (fi) 1991-03-28
DK406086A (da) 1987-02-28
ATA231786A (de) 1990-12-15
FR2586686B1 (fr) 1990-02-02
HUT44035A (en) 1988-01-28
GB2179649B (fr) 1989-10-25
DK406086D0 (da) 1986-08-26
AU604464B2 (en) 1990-12-20
KR870002269A (ko) 1987-03-30

Similar Documents

Publication Publication Date Title
DE2532568C3 (de) Aclacinomycin A und B, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE2510866B2 (de) 4'-epi-Adriamycin a - und ß -Anomer, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE3436137C2 (de) Antibiotika BBM-2478A und BBM-2478B, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel
DE3881576T2 (de) Anthracyclinderivate und ihre Verwendung.
AT392971B (de) Verfahren zur herstellung neuer antitumor-antibiotika
EP0131181A2 (fr) Dérivés d'anthracyclines, une méthode microbiologique pour leur préparation et leur emploi comme agents cytostatiques
DE2831579C3 (de) Tetrahydropyranylether von Daunomycin und Adriamycin, Verfahren zu ihrer Herstellung, sowie diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE69020645T2 (de) Antitumor- und Antibiotikum-Substanz, ihre Herstellung und Verwendungen.
DE2724597C3 (de) 3'-Desoxykanamycin C und 3\4'-Didesoxykanamycin C, deren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende antibakterielle Mittel
DE2715255B2 (de) Anthracyclinglykoside MA 144-M1 und MA 144-M2 und deren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
EP0286926B1 (fr) Rhodomycines semi-synthétiques, leur méthode de préparation et leur utilisation comme cytostatique
DE2724441A1 (de) Anthracyclinglycoside, verfahren zu ihrer herstellung und arzneimittel
EP0021215A1 (fr) Pseudotrisaccharides, leur préparation et utilisation comme médicaments
EP0167954B1 (fr) 1-Hydroxy-cytorhodines, une méthode microbiologique pour leur préparation et leur emploi comme agents cytostatiques
DE69312512T2 (de) Etoposid-derivate, ihre herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
EP0186807B1 (fr) Dérivés d'anthracyclines, leur préparation microbiologique et leur utilisation comme médicament
EP0660825B1 (fr) Macrolactame (cyclamenol) anti-inflammatoire
DE2118636A1 (de) 3-Nucleotide von Lincomycin und deren Analogen, Verfahren zu ihrer Herstellung und ihre Verwendung in therapeutischen Präparaten
DE1643521B2 (de) 4'-demethyl-epipodophyllotoxin-beta-d- glucosidderivate sowie ein verfahren zu ihrer herstellung und arzneimittel mit einem gehalt dieser verbindungen
DE3008631A1 (de) Neue spectinomycin-analoge und verfahren zu ihrer herstellung
DE3008649C2 (fr)
EP0345598A2 (fr) Dérivés d'anthracyclines à activité cytostatique
DE60117526T2 (de) Alkylierte inositolglycane und ihre verwendung
DE2738656C2 (fr)
EP0272734A2 (fr) 3-Amino-3,4,6-tridésoxyglycals, leur méthode de préparation et les anthracyclines obtenus à l'aide de ces glycals

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: BRISTOL-MYERS SQUIBB CO. (N.D.GES.D.STAATES DELAWA

8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee